UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000036540
Receipt No. R000041633
Scientific Title A validation study of efficacy of image fusion technique using magnetic position tracking system (Real-time virtual sonography or Volume navigation) for the localization of breast cancer with non-mass enhancement in breast conserving surgery (prospective multicenter study) : FUSION 02 study
Date of disclosure of the study information 2019/09/01
Last modified on 2020/10/20 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A validation study of efficacy of image fusion technique using magnetic position tracking system (Real-time virtual sonography or Volume navigation) for the localization of breast cancer with non-mass enhancement in breast conserving surgery (prospective multicenter study) : FUSION 02 study
Acronym FUSION 02 study
Scientific Title A validation study of efficacy of image fusion technique using magnetic position tracking system (Real-time virtual sonography or Volume navigation) for the localization of breast cancer with non-mass enhancement in breast conserving surgery (prospective multicenter study) : FUSION 02 study
Scientific Title:Acronym FUSION 02 study
Region
Japan

Condition
Condition Breast cancer with non-mass enhancement (NME) detected by MRI
Classification by specialty
Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate whether Real-time virtual sonography (RVS)/Volume navigation (Vnav) contribute to the improvement of margin positive rate of breast cancer with NME in breast conserving surgery by prospective multicenter cohort study
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Phase II

Assessment
Primary outcomes The rate of margin positive after pre-operative marking using RVS/Vnav in breast conserving surgery for breast cancer with NME
Key secondary outcomes 1) The detection rate of NME in supine MRI
2) The required time to detect the border of the area of NME by using RVS/Vnav
3) The required time to put the breast tissue marker at the border of the area NME
4) The detection rate of the breast tissue marker by the pre-operative ultrasound
5) Operation time and weight of resected specimen in breast conserving surgery,
6) Distance between breast tissue marker and pathological surgical margin
7) The re-operation rate and re-operation operative method

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Fusion imaging technique using Ultrasound ( RVS / Vnav )
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1) A patient who has a breast cancer with NME in breast MRI examination
2) Female aged over 20 years old
3) Performance status 0, 1
4) Agreement on informed consent for this clinical trial
Key exclusion criteria 1) A patient with a pacemaker
2) A patient with allergy for a contrast medium for MRI
3) A patient with a metallic artificial heart valve
4) A patient with past asthmatic symptom
5) A patient with a severe renal dysfunction
6) A patient with a severe claustrophobia
7) A patient with a tattoo
8) A patient who is not able to perform breast MRI with some reasons.
9) A patient who is pregnant or a patient who has a possibility of being pregnant
10) A patient who is lactating
11) A patient who is not able to perform breast conserving surgery
12) A patient who has a history of mental disorder or central nervous disorder
13) A patient who was received neoadjuvant chemotherapy.
14) A patient with allergy for a titanium
15) A patient with allergy for a xylocaine
16) A patient who is not considered suitable by doctors
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Shogo
Middle name
Last name Nakano
Organization Aichi Medical University
Division name Division of Breast and Endocrine Surgery, Department of Surgery
Zip code 480-1195
Address 1-1 Yazakokarimata, Nagate-city, Aichi, Japan
TEL 0561-62-3311
Email snakano1@aichi-med-u.ac.jp

Public contact
Name of contact person
1st name Shogo
Middle name
Last name Nakano
Organization Aichi Medical University
Division name Division of Breast and Endocrine Surgery, Department of Surgery
Zip code 480-1195
Address 1-1 Yazakokarimata, Nagate-city, Aichi, Japan
TEL 0561-62-3311
Homepage URL
Email snakano1@aichi-med-u.ac.jp

Sponsor
Institute Aichi Medical University
Institute
Department

Funding Source
Organization Aichi Medical University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Aichi Medical University
Address 1-1 Yazakokarimata, Nagate-city, Aichi, Japan
Tel 0561-62-3311
Email snakano1@aichi-med-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 愛知医科大学病院(愛知県)、大垣市民病院(岐阜県)

Other administrative information
Date of disclosure of the study information
2019 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 02 Month 17 Day
Date of IRB
2019 Year 02 Month 28 Day
Anticipated trial start date
2019 Year 03 Month 12 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 04 Month 18 Day
Last modified on
2020 Year 10 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000041633